LINC01882

Across TCGA pan-cancer cohorts, LINC01882 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01882 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01882 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01882 expression acts as an unfavorable survival marker, although some lineages such as LUAD and READ show a favorable association.

COAD, GBM, and LGG are the cancer types where LINC01882 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	IV	0.149	0.755	<.001	57	view →
GBM	OS	Median	All	0.328	0.483	<.001	42	view →
LGG	OS	Median	All	0.755	0.859	<.001	37	view →
LUAD	OS	Tertile	II,III,IV	0.620	0.422	.020	23	view →
READ	OS	Median	IV	0.920	0.519	.010	20	view →
ESCA	DFS	Tertile	III,IV	0.552	0.258	.001	18	view →
THYM	OS	Median	All	0.965	0.766	.007	15	view →
BLCA	DFS	Quartile	IV	0.287	0.612	.008	12	view →
THCA	DFS	Median	IV	0.577	0.984	.003	9	view →
SKCM	OS	Median	All	0.390	0.295	.012	7	view →
CESC	OS	Quartile	All	0.831	0.715	.042	6	view →
OV	DFS	Quartile	IV	0.449	0.268	.043	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01882–COAD (DFS)

Open the COAD breakdown →